Xanax (alprazolam recalls
The FDA has published 2 recalls involving Xanax (alprazolam since 2016. The latest was reported on 18 May 2022. Most were for labeling errors. Viatris has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why xanax (alprazolam is recalled
Companies
By year
All xanax (alprazolam recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Xanax XR (alprazolam) extended-release tablets, 3 mg recalled by Viatris | Viatris | Potency & Assay | Nationwide |
| Drug | CLASS III | Xanax (Alprazolam) USP, CIV recalled by Mckesson Packaging Services | Mckesson Packaging Services | Labeling Errors | 4 states |
Should you stop taking Xanax (alprazolam?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.